Gene · 2101
Papers2,737
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,737
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Relationship Between Myocardial Injury and Expression of PGC-1α and Its Coactivators in Chronic Keshan Disease. | Curr Med Sci | 2022 | 34705216 | PubTator, text mining | PubMed |
| UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase/deubiquitinase-substrate interactions in eukaryotic species. | Nucleic Acids Res | 2022 | 34669962 | PubTator, text mining | PubMed |
| Molecular dynamics of estrogen-related receptors and their regulatory proteins: roles in transcriptional control for endocrine and metabolic signaling. | Anat Sci Int | 2022 | 34609710 | PubTator, text mining | PubMed |
| Respiratory Complex I dysfunction in cancer: from a maze of cellular adaptive responses to potential therapeutic strategies. | FEBS J | 2022 | 34606156 | PubTator, text mining | PubMed |
| Clinical epigenetics and restoring of metabolic health in severely obese patients undergoing batriatric and metabolic surgery. | Updates Surg | 2022 | 34599748 | PubTator, text mining | PubMed |
| Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives. | Obes Rev | 2022 | 34559450 | PubTator, text mining | PubMed |
| MicroRNAs as a clue to overcome breast cancer treatment resistance. | Cancer Metastasis Rev | 2022 | 34524579 | PubTator, text mining | PubMed |
| Recent Developments in PROTAC-Mediated Protein Degradation: From Bench to Clinic. | Chembiochem | 2022 | 34494353 | PubTator, text mining | PubMed |
| miR-137/ERRα axis mediates chemoresistance of nasopharyngeal carcinoma cells. | J Cell Commun Signal | 2022 | 34196940 | PubTator, text mining | PubMed |
The ERRα-VDR axis promotes calcitriol degradation and estrogen signaling in breast cancer cells, while VDR-CYP24A1-ERRα overexpression correlates with poor prognosis in patients with basal-like breast cancer. | Mol Oncol | 2022 | 34003583 | PubTator, text mining | PubMed |
| Identifying anti-TNF response biomarkers in ulcerative colitis using a diffusion-based signalling model. | Bioinform Adv | 2021 | 36700114 | PubTator, text mining | PubMed |
| Aerobic High-Intensity Exercise Training Improves Cardiovascular Health in Older Post-menopausal Women. | Front Aging | 2021 | 35822005 | PubTator, text mining | PubMed |
| Inward Outward Signaling in Ovarian Cancer: Morpho-Phospho-Proteomic Profiling Upon Application of Hypoxia and Shear Stress Characterizes the Adaptive Plasticity of OVCAR-3 and SKOV-3 Cells. | Front Oncol | 2021 | 35251951 | PubTator, text mining | PubMed |
| The Interaction Between Intracellular Energy Metabolism and Signaling Pathways During Osteogenesis. | Front Mol Biosci | 2021 | 35155568 | PubTator, text mining | PubMed |
| Understanding the Emerging Link Between Circadian Rhythm, Nrf2 Pathway, and Breast Cancer to Overcome Drug Resistance. | Front Pharmacol | 2021 | 35126099 | PubTator, text mining | PubMed |
| The Response of the Estrogen-Related Receptor to 20-Hydroxyecdysone in Bombyx mori: Insight Into the Function of Estrogen-Related Receptor in Insect 20-Hydroxyecdysone Signaling Pathway. | Front Physiol | 2021 | 35115955 | PubTator, text mining | PubMed |
| A Review on the Role of SPRY4-IT1 in the Carcinogenesis. | Front Oncol | 2021 | 35096580 | PubTator, text mining | PubMed |
| Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients. | Front Immunol | 2021 | 35095892 | PubTator, text mining | PubMed |
| Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem Cells. | Front Cell Dev Biol | 2021 | 35083221 | PubTator, text mining | PubMed |
| Usefulness of Melatonin and Other Compounds as Antioxidants and Epidrugs in the Treatment of Head and Neck Cancer. | Antioxidants (Basel) | 2021 | 35052539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2101/papers?page=39